MedPath

Treatment of Chronic Rhinosinusitis with Unani Medicine Itrifal Zamani.

Phase 2
Conditions
Health Condition 1: J329- Chronic sinusitis, unspecifiedHealth Condition 2: null- Nazla Muzmin (Chronic Rhinosinusitis)
Registration Number
CTRI/2018/08/015444
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of any in the age group of 18 to 60 years

2. Radiologically diagnosed Rhinosinusitis of more than12 weeks duration

3. SNOT Score > 11

Exclusion Criteria

1. Rhinosinusitis /Sinusitis of < 12 weeks

2. Deviated Nasal septum

3. Nasal polyps

4. Local pathology such as mucocele, cyst, antrochoanal polyp, facial trauma, radiation injury, or birth defect

5. Diabetes mellitus and any other illness requiring long term treatment

6. Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement in the sign and symptoms of Nazla Muzmin (Chronic Rhinosinusitis)Timepoint: six weeks
Secondary Outcome Measures
NameTimeMethod
Hematological and biochemical assessments for safetyTimepoint: six weeks
© Copyright 2025. All Rights Reserved by MedPath